Document is current
Any future updates will be listed below
-
Authors
Blok, Siebe G. https://orcid.org/0000-0001-6169-2862
Mousa, Amne
Brouwer, Michelle G.
de Grooth, Harm-Jan
Neto, Ary Serpa
Blans, Michiel J.
den Boer, Sylvia
Dormans, Tom
Endeman, Henrik
Roeleveld, Timo
Scholten, Harm
van Slobbe-Bijlsma, Eline R.
Scholten, Erik
Touw, Hugo
van der Ven, Fleur Stefanie L. I. M.
Wils, Evert-Jan
van Westerloo, David J.
Heunks, Leo M. A.
Schultz, Marcus J.
Paulus, Frederique
Tuinman, Pieter R.
-
Funding
Funding for this research was provided by:
ZonMw (852002121)
- License Information
-
More Information
Article History
Received: 16 December 2022
Accepted: 14 February 2023
First Online: 24 March 2023
Declarations
:
: The trial received ethical approval from the medical ethics review committee of the Amsterdam UMC, location AMC, on 29.11.2021 with reference number 2021_182. The sponsor and participating centres have liability insurance. This study compares management strategies already used in clinical care and therefore exemption from the requirement to insure cover for damage to research subjects through injury or death caused by the study is applicable. Deferred informed consent to participate will be obtained from all participants. No biological specimens are stored.
: Not applicable.
: Marcus J. Schultz reports personal fees from Hamilton Medical, outside of the submitted work. David J. van Westerloo reports receiving a research grant from Philips, outside of the submitted work. The other authors declare no competing interests.
